Prevalence of anticardiolipin antibodies in various thrombotic conditions: A hospital-based study

S. Chandrashekhara, R. Kirthi, Joyce Varghese

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Thrombosis is one of the leading cause of death, globally, anticardiolipin antibodies (aCL) has been implicated as one of the most common acquired protein defect causing thrombosis. This study was undertaken to evince the incidence of aCL in various thrombotic settings. Material and Methods: Three hundred and two patients were retrospectively screened for the incidence of aCL. The sera were screened for aCL IgG using enzyme linked immunosorbent assay. Detail clinical and epidemiological data were obtained from hospital records and clinical examination. Results: Among the 302 patients, 134 (44.37%) were below the age of 40 years (juvenile-onset thrombosis), mean age being 35.3 years. High titres of aCL IgG was seen in 65 (20.77%) patients. Deep vein thrombosis (DVT), seen in 90 (29.8%) was the most common thrombotic condition. Other sites of thrombosis were coronary artery (19.2%), central nervous system territory arteries (17.21%) and peripheral arteries (5.29%); the incidence of aCL IgG in these sites were 13.79%, 25.0% and 18.75% respectively. Conclusion: aCL is the most common acquired thrombophilic defect. Epidemiological data of our population is required for evaluating the strategy for further research of thrombosis in this condition.

Original languageEnglish (US)
Pages (from-to)359-362
Number of pages4
JournalJournal of Association of Physicians of India
Volume51
Issue numberAPR
StatePublished - 2003

Fingerprint

Anticardiolipin Antibodies
Thrombosis
Immunoglobulin G
Incidence
Arteries
Hospital Records
Venous Thrombosis
Cause of Death
Coronary Vessels
Central Nervous System
Enzyme-Linked Immunosorbent Assay
Serum
Research
Population

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Prevalence of anticardiolipin antibodies in various thrombotic conditions : A hospital-based study. / Chandrashekhara, S.; Kirthi, R.; Varghese, Joyce.

In: Journal of Association of Physicians of India, Vol. 51, No. APR, 2003, p. 359-362.

Research output: Contribution to journalArticle

@article{565791e1a66d4ccbb507dcf17153c6fe,
title = "Prevalence of anticardiolipin antibodies in various thrombotic conditions: A hospital-based study",
abstract = "Thrombosis is one of the leading cause of death, globally, anticardiolipin antibodies (aCL) has been implicated as one of the most common acquired protein defect causing thrombosis. This study was undertaken to evince the incidence of aCL in various thrombotic settings. Material and Methods: Three hundred and two patients were retrospectively screened for the incidence of aCL. The sera were screened for aCL IgG using enzyme linked immunosorbent assay. Detail clinical and epidemiological data were obtained from hospital records and clinical examination. Results: Among the 302 patients, 134 (44.37{\%}) were below the age of 40 years (juvenile-onset thrombosis), mean age being 35.3 years. High titres of aCL IgG was seen in 65 (20.77{\%}) patients. Deep vein thrombosis (DVT), seen in 90 (29.8{\%}) was the most common thrombotic condition. Other sites of thrombosis were coronary artery (19.2{\%}), central nervous system territory arteries (17.21{\%}) and peripheral arteries (5.29{\%}); the incidence of aCL IgG in these sites were 13.79{\%}, 25.0{\%} and 18.75{\%} respectively. Conclusion: aCL is the most common acquired thrombophilic defect. Epidemiological data of our population is required for evaluating the strategy for further research of thrombosis in this condition.",
author = "S. Chandrashekhara and R. Kirthi and Joyce Varghese",
year = "2003",
language = "English (US)",
volume = "51",
pages = "359--362",
journal = "Journal of Association of Physicians of India",
issn = "0004-5772",
publisher = "Journal of Association of Physicians of India",
number = "APR",

}

TY - JOUR

T1 - Prevalence of anticardiolipin antibodies in various thrombotic conditions

T2 - A hospital-based study

AU - Chandrashekhara, S.

AU - Kirthi, R.

AU - Varghese, Joyce

PY - 2003

Y1 - 2003

N2 - Thrombosis is one of the leading cause of death, globally, anticardiolipin antibodies (aCL) has been implicated as one of the most common acquired protein defect causing thrombosis. This study was undertaken to evince the incidence of aCL in various thrombotic settings. Material and Methods: Three hundred and two patients were retrospectively screened for the incidence of aCL. The sera were screened for aCL IgG using enzyme linked immunosorbent assay. Detail clinical and epidemiological data were obtained from hospital records and clinical examination. Results: Among the 302 patients, 134 (44.37%) were below the age of 40 years (juvenile-onset thrombosis), mean age being 35.3 years. High titres of aCL IgG was seen in 65 (20.77%) patients. Deep vein thrombosis (DVT), seen in 90 (29.8%) was the most common thrombotic condition. Other sites of thrombosis were coronary artery (19.2%), central nervous system territory arteries (17.21%) and peripheral arteries (5.29%); the incidence of aCL IgG in these sites were 13.79%, 25.0% and 18.75% respectively. Conclusion: aCL is the most common acquired thrombophilic defect. Epidemiological data of our population is required for evaluating the strategy for further research of thrombosis in this condition.

AB - Thrombosis is one of the leading cause of death, globally, anticardiolipin antibodies (aCL) has been implicated as one of the most common acquired protein defect causing thrombosis. This study was undertaken to evince the incidence of aCL in various thrombotic settings. Material and Methods: Three hundred and two patients were retrospectively screened for the incidence of aCL. The sera were screened for aCL IgG using enzyme linked immunosorbent assay. Detail clinical and epidemiological data were obtained from hospital records and clinical examination. Results: Among the 302 patients, 134 (44.37%) were below the age of 40 years (juvenile-onset thrombosis), mean age being 35.3 years. High titres of aCL IgG was seen in 65 (20.77%) patients. Deep vein thrombosis (DVT), seen in 90 (29.8%) was the most common thrombotic condition. Other sites of thrombosis were coronary artery (19.2%), central nervous system territory arteries (17.21%) and peripheral arteries (5.29%); the incidence of aCL IgG in these sites were 13.79%, 25.0% and 18.75% respectively. Conclusion: aCL is the most common acquired thrombophilic defect. Epidemiological data of our population is required for evaluating the strategy for further research of thrombosis in this condition.

UR - http://www.scopus.com/inward/record.url?scp=0038052297&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0038052297&partnerID=8YFLogxK

M3 - Article

C2 - 12723649

AN - SCOPUS:0038052297

VL - 51

SP - 359

EP - 362

JO - Journal of Association of Physicians of India

JF - Journal of Association of Physicians of India

SN - 0004-5772

IS - APR

ER -